Insights

In “Aggregated Precision Investment: Strengths, Weaknesses, and Potential Paths Forward,” Rebecca Nielsen, Brooke Zollinger, and Sarah Johnson from Leavitt Partners explore the feasibility of operationalizing an aggregated precision investment (API) model for social determinants of health (SDOH) interventions. The authors derive their findings from subject matter expert interviews, conversations with potential aggregators, and relevant secondary research. This article enumerates … Read more

Featured Experts

Amy Comstock Rick, former president and chief executive officer (CEO) of the Food and Drug Law Institute (FDLI), joined Leavitt Partners, an HMA Company as a principal on March 20. Rick has over 30 years of experience leading organizations, executing strategy, transforming organizational culture, building consensus, and advocating policies across constituencies. “Amy is widely respected … Read more

Data science and digital health in clinical development and operations: impact, challenges, and calls to action for the drug development ecosystem In this paper, the Medicines Development Modernization Initiative discuss how three medicines development tools (MDTs) – artificial intelligence (AI) and machine learning (ML) algorithms, digital health tools (DHTs), and augmentation of randomized controlled trial … Read more

Pharmacy provision of clinical services is important to patient access and outcomes. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes more important to the healthcare system at-large. Pharmacy teams’ ability to provide optimal care and meaningfully contribute to the value-based care transformation depends on their ability to access and … Read more

Today, Leavitt Partners, an HMA Company released a report outlining steps federal and state policymakers, technology and electronic health record (EHR) companies, health plans, pharmacies, and other healthcare providers can take to strengthen pharmacy data interoperability. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes increasingly important to patients and … Read more

Washington, D.C., March 22, 2023 — The CARIN Alliance, a multi-sector collaborative of healthcare and other stakeholders working to advance the consumer-directed exchange of health information released a report today that lays the foundation for how individuals can voluntarily digital identity proof themselves once and use that same digital credential with multiple data holders of … Read more

Digital health has experienced a rapid transformation in the last two years since the beginning of the COVID-19 pandemic, dramatically shifting how care is delivered to patients. To better understand the rapid changes occurring in the industry and capitalize on future market movements, Leavitt Partners has created a digital health taxonomy and standardized definitions, along with robust market segmentations and … Read more

As efforts continued at the beginning of 2022 to implement the No Surprises Act aimed at preventing surprise medical bills that patients are often unable to pay, the Kaiser Family Foundation published a report that estimates nearly one in 10 adults have medical debt, and that Americans’ total medical debt could be as high as $195 billion. … Read more

Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Read more